ZARGUS 2 MG COM REV CT BL AL PLAS TRANS X 20
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1057305990046 -
GGREM
552920020110317 -
Código de barras
7896181902980
O que a fonte publica
- Detentor do registro
- ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A
- Princípios ativos
- RISPERIDONA
- Embalagem
- 2 MG COM REV CT BL AL PLAS TRANS X 20
- Regime de dispensação
- Tarja Vermelha sob restrição
- Tipo de produto
- Similar
- Classe terapêutica
- N5A1 - ANTIPSICÓTICOS ATÍPICOS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "ZARGUS 2 MG COM REV CT BL AL PLAS TRANS X 20",
"holder": "ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"7896181902980"
],
"confaz87": true,
"currency": "BRL",
"marketed": null,
"ggremCode": "552920020110317",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "60.659.463/0029-92",
"priceRegime": "Regulado",
"productName": "ZARGUS",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "2 MG COM REV CT BL AL PLAS TRANS X 20",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "131.16",
"icms-12": "149.05",
"icms-17": "158.02",
"icms-18": "159.95",
"icms-19": "161.93",
"icms-20": "163.95",
"icms-21": "166.03",
"icms-22": "168.15",
"icms-23": "170.34",
"icms-17.5": "158.98",
"icms-19.5": "162.93",
"icms-20.5": "164.98",
"icms-22.5": "169.24",
"icms-12-alc": "147.26",
"icms-17-alc": "156.13",
"icms-18-alc": "158.03",
"icms-19-alc": "159.98",
"icms-20-alc": "161.98",
"icms-21-alc": "164.03",
"icms-22-alc": "166.14",
"icms-23-alc": "168.29",
"withoutTaxes": "129.59",
"icms-17.5-alc": "157.07",
"icms-19.5-alc": "160.98",
"icms-20.5-alc": "163.00",
"icms-22.5-alc": "167.21"
},
"pisCofinsList": "Positiva",
"substanceText": "RISPERIDONA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "180.79",
"icms-12": "205.45",
"icms-17": "217.81",
"icms-18": "220.47",
"icms-19": "223.20",
"icms-20": "225.99",
"icms-21": "228.86",
"icms-22": "231.78",
"icms-23": "234.80",
"icms-17.5": "219.14",
"icms-19.5": "224.58",
"icms-20.5": "227.41",
"icms-22.5": "233.28",
"icms-12-alc": "203.58",
"icms-17-alc": "215.84",
"icms-18-alc": "218.47",
"icms-19-alc": "221.16",
"icms-20-alc": "223.93",
"icms-21-alc": "226.76",
"icms-22-alc": "229.68",
"icms-23-alc": "232.65",
"withoutTaxes": "179.15",
"icms-17.5-alc": "217.14",
"icms-19.5-alc": "222.55",
"icms-20.5-alc": "225.34",
"icms-22.5-alc": "231.16"
},
"invalidBarcodes": [],
"activeSubstances": [
"RISPERIDONA"
],
"therapeuticClass": "N5A1 - ANTIPSICÓTICOS ATÍPICOS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1057305990046",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N5A1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:552920020110317"